En Es
Categories

Industry News

AI Predicts Alzheimer’s Disease Years before Diagnosis

By Medimaging International staff writers
23 Nov 2018

Image: Saliency map of deep learning model Inception V3 on the classification of Alzheimer disease. (a) A representative saliency map with anatomic overlay in 77-year-old man. (b) Average saliency map over 10 percent of Alzheimer’s Disease Neuroimaging Initiative set. (c) Average saliency map over independent test set. The closer a pixel color is to the A new study on the application of deep learning (DL) to detect changes in brain metabolism predictive of Alzheimer’s disease (AD) has found that artificial intelligence (AI) improves the ability of brain imaging to predict AD.

Timely diagnosis of AD is extremely important, although early diagnosis has proven to be challenging. Research has linked the disease process to changes in metabolism, as shown by glucose uptake in certain regions of the brain, although these changes can be difficult to recognize.

The researchers trained the DL algorithm using an 18-F-fluorodeoxyglucose PET (FDG-PET) scan. They had access to data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a major multi-site study focused on clinical trials to improve prevention and treatment of the disease. The ADNI dataset included more than 2,100 FDG-PET brain images from 1,002 patients. The researchers trained the DL algorithm on 90% of the dataset and then tested it on the remaining 10% of the dataset. Finally, the researchers tested the algorithm on an independent set of 40 imaging exams from 40 patients that it had never studied. The algorithm achieved 100% sensitivity at detecting the disease an average of more than six years prior to the final diagnosis.

According to the researchers, the algorithm could be a useful tool to complement the work of radiologists — especially in conjunction with other biochemical and imaging tests — in providing an opportunity for early therapeutic intervention. The researchers will now focus on training the DL algorithm to look for patterns associated with the accumulation of beta-amyloid and tau proteins, abnormal protein clumps and tangles in the brain that are markers specific to AD.

“If we diagnose Alzheimer’s disease when all the symptoms have manifested, the brain volume loss is so significant that it’s too late to intervene,” said study co-author Jae Ho Sohn, MD, from the Radiology & Biomedical Imaging Department at the University of California in San Francisco (UCSF). “If we can detect it earlier, that’s an opportunity for investigators to potentially find better ways to slow down or even halt the disease process.”

Related Links:
University of California in San Francisco



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

20 May 2019
Beckman Coulter Introduces New Total Laboratory Automation Solution
Beckman Coulter’s latest addition to its automation portfolio, the DxA 5000 total laboratory automation solution has achieved European CE Mark and China Food and Drug Administration approval.
Read More
20 May 2019
Ortho Clinical Diagnostics Presents Cardiac Advances at EuroMedLab 2019
Ortho Clinical Diagnostics sponsored an educational workshop on high-sensitivity troponin assays and presented five scientific posters at EuroMedLab 2019, the 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, which took place from May 19-23, 2019, at the CCIB - Centre Convencions Internacional in Barcelona.
Read More
18 May 2019
AI More Accurate at Predicting Heart Attacks than Physicians
Researchers from the Turku PET Centre have developed an algorithm that “learned” how imaging data interacts by repeatedly analyzing 85 variables in 950 patients with known six-year outcomes.
Read More
18 May 2019
New AI Method Predicts Breast Cancer Five Years in Advance
Researchers from two major institutions have developed a new tool with advanced artificial intelligence (AI) methods to predict a woman’s future risk of breast cancer.
Read More
18 May 2019
Weak AI security Exposes IoT Medical Devices to Risk of Cyberattacks
The proliferation of healthcare internet-of-things (IoT) devices, along with unpartitioned networks, insufficient access controls and the reliance on legacy systems has exposed a vulnerable attack surface that can be exploited by cybercriminals determined to steal personally identifiable information (PII) and protected health information (PHI), in addition to disrupting healthcare delivery processes.
Read More
18 May 2019
Disposable Anesthesia Device Demand Driven by Lower Risk of Transmitting Infections
The global anesthesia devices market is expected to register a CAGR of more than 6% during the period 2019-2023, driven by increasing demand due to advances in anesthesia technology and growing demand for disposable anesthesia devices.
Read More
18 May 2019
MRI Systems Market to Reach USD 11.72 Billion by 2025
The global Magnetic Resonance Imaging (MRI) systems market is expected to grow at a CAGR of 6.4% between 2018 and 2025 to reach USD 11.72 billion by 2025, driven by increased healthcare spending and sophisticated healthcare infrastructure in the developed nations, as well as recent technological advancements.
Read More
18 May 2019
New AR Patient Solution Applies VR to Thoracic Surgery
Surgical Theater, a provider of virtual and augmented reality healthcare services, has launched its first ever 360° Augmented Reality (AR) patient engagement solution that will allow thoracic surgeons to view patient-specific virtual reconstructions in AR.
Read More
08 May 2019
Technological Advancements and Multi-Modality Systems Driving X-ray Detector Market
The global healthcare X-ray detectors market is projected to grow at a CAGR of 6.14% during the forecast period 2018-2024, driven primarily by technological advancements and adoption of multi-modality imaging systems in hospitals.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions